Inventor · disambiguated record
Jeevan Ghosalkar
Also filed as: Ghosalkar Jeevan
17 granted patents·14 pending applications·5 citations·filing 2016–2023
88Inventor score
Top patents by PatentIndex Score
31 records- 0181US10709715B2Method of treating hypertensionCIPLA LTD·Filed 2018·Granted Jul 14, 2020·1 cites·21 claims
- 0280US10391080B2Ketorolac for the treatment of cancerCIPLA LTD·Filed 2017·Granted Aug 27, 2019·1 cites·15 claims
- 0380US9867865B1Mesalamine for the treatment of cancerCIPLA LTD·Filed 2017·Granted Jan 16, 2018·1 cites·17 claims
- 0477US2024016814A1Method of treating hypertensionCIPLA LTD·Filed 2023·Application pending·0 cites
- 0576US9937160B2Thienopyridine derivative for the treatment of hepatitis C infectionsCIPLA UK LTD·Filed 2016·Granted Apr 10, 2018·1 cites·7 claims
- 0673US11129836B2PAR-4 agonists for the treatment of cancerCIPLA LTD·Filed 2019·Granted Sep 28, 2021·0 cites·8 claims
- 0772US12090163B2Pharmaceutical compositionsCIPLA LTD·Filed 2018·Granted Sep 17, 2024·1 cites·20 claims
- 0870US2021401851A1Par-4 agonists for the treatment of cancerCIPLA LTD·Filed 2021·Application pending·0 cites
- 0970US2023030113A1Method of treating hypertensionCIPLA LTD·Filed 2022·Application pending·0 cites
- 1069US10857113B2Bezafibrate for the treatment of cancerCIPLA LTD·Filed 2018·Granted Dec 8, 2020·0 cites·5 claims
- 1168US11478483B2Method of treating hypertensionCIPLA LTD·Filed 2018·Granted Oct 25, 2022·0 cites·13 claims
- 1266US2019125756A1Method of treating hypertensionCIPLA LTD·Filed 2018·Application pending·0 cites
- 1365US11612612B2Pharmaceutical compositionsCIPLA LTD·Filed 2020·Granted Mar 28, 2023·0 cites·14 claims
- 1465US10220072B2Mesalamine for the treatment of cancerCIPLA LTD·Filed 2017·Granted Mar 5, 2019·0 cites·20 claims
- 1565US10098860B2Bezafibrate for the treatment of cancerCIPLA LTD·Filed 2017·Granted Oct 16, 2018·0 cites·15 claims
- 1665US10058545B2Method of treating pulmonary arterial hypertensionCIPLA LTD·Filed 2017·Granted Aug 28, 2018·0 cites·13 claims
- 1764US10471048B2Thienopyridine derivative for the treatment of hepatitis C infectionsCIPLA UK LTD·Filed 2018·Granted Nov 12, 2019·0 cites·10 claims
- 1864US2020405729A1Method of treating hypertensionCIPLA LTD·Filed 2020·Application pending·0 cites
- 1962US11040041B2Method of treating pulmonary arterial hypertensionCIPLA UK LTD·Filed 2020·Granted Jun 22, 2021·0 cites·12 claims
- 2062US2017368072A1Par-4 agonists for the treatment of cancerCIPLA LTD·Filed 2017·Application pending·0 cites
- 2159US10039752B2Methazolamide for the treatment of cancerCIPLA LTD·Filed 2017·Granted Aug 7, 2018·0 cites·19 claims
- 2259US2018344718A1Method of treating hypertensionCIPLA LTD·Filed 2018·Application pending·0 cites
- 2358US10576083B2Method of treating pulmonary arterial hypertensionCIPLA UK LTD·Filed 2016·Granted Mar 3, 2020·0 cites·12 claims
- 2457US2024009214A1Method of Treating Viral InfectionCIPLA LTD·Filed 2021·Application pending·0 cites
- 2552US11224591B2Pharmaceutical compositions comprising rifaximinCIPLA LTD·Filed 2017·Granted Jan 18, 2022·0 cites·10 claims
- 2652US2021299098A1Selective estrogen receptor modulator for treatment of pancreatic cancerCIPLA LTD·Filed 2021·Application pending·0 cites
- 2751US2022193043A1Pharmaceutical Combination Formulations Comprising Tizanidine, Resveratrol and PiperineCIPLA LTD·Filed 2020·Application pending·0 cites
- 2850US2021100786A1Pharmaceutical FormulationsCIPLA LTD·Filed 2019·Application pending·0 cites
- 2949US2020215074A1Method of Treatment of CancerCIPLA LTD·Filed 2018·Application pending·0 cites
- 3046US2018092895A1Method of treatment of hepatitis cCIPLA LTD·Filed 2017·Application pending·0 cites
- 3145US2017232020A1Pharmaceutical compositionsCIPLA LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →